The George Institute
OrganisationROR
Trials
HFrEF Polypill in Sri Lanka RCT
Collaborator, Phase 3, Recruiting, 2026, 1,672 people, 6 May 2026, clinicaltrials.gov
Phase 3, Recruiting, 2025, 2,000 people, 8 Jan 2025, clinicaltrials.gov
Collaborator, Phase 2, Recruiting, 2024, 69 people, 19 Sept 2024, clinicaltrials.gov
Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)
Phase 3, Withdrawn, 2024, 0 people, 19 Aug 2024, clinicaltrials.gov
The Impact of Community Health Workers on the Uptake of Preventative Care Services in London, UK
Collaborator, No phase, Completed, 2024, 7,200 people, 22 Nov 2023, clinicaltrials.gov
Phase 3, Recruiting, 2024, 2,000 people, 28 Sept 2023, clinicaltrials.gov
Collaborator, Phase 2, Withdrawn, 2024, 0 people, 27 Apr 2023, clinicaltrials.gov
Phase 3, Terminated, 2023, 51 people, 21 Jul 2022, clinicaltrials.gov
Phase 3, Recruiting, 2023, 994 people, 25 Apr 2022, clinicaltrials.gov
Collaborator, Phase 2/3, Withdrawn, 2023, 0 people, 11 Jan 2022, clinicaltrials.gov
Phase 4, Terminated, 2022, 3 people, 22 Nov 2021, clinicaltrials.gov
Phase 3, Active, not recruiting, 2022, 190 people, 27 May 2021, clinicaltrials.gov
Phase 4, Completed, 2020, 787 people, 19 May 2020, clinicaltrials.gov
Collaborator, Phase 4, Active, not recruiting, 2020, 9,082 people, 8 May 2020, clinicaltrials.gov
Collaborator, Phase 2, Completed, 2019, 151 people, 17 Jun 2019, clinicaltrials.gov
Collaborator, Phase 3, Completed, 2013, 5,177 people, 8 Nov 2011, clinicaltrials.gov
Named in competing interests
Shares or equity, 5 Oct 2026, pubmed.ncbi.nlm.nih.gov
Recommendations for the management of frailty in chronic kidney disease: a consensus report
Fees or honoraria, 25 Sept 2026, pubmed.ncbi.nlm.nih.gov